Cargando…
Role of Intraparotid and Neck Lymph Node Metastasis in Primary Parotid Cancer Surgery: A Population-Based Analysis
SIMPLE SUMMARY: The prognostic role of intraparotid (PAR) and cervical lymph node (LN) metastasis on overall survival (OS) of primary parotid cancer is unclear. All 345 Thuringian patients with parotid cancer from 1996 to 2016 were included in a population-based study. OS was assessed in relation to...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220808/ https://www.ncbi.nlm.nih.gov/pubmed/35740490 http://dx.doi.org/10.3390/cancers14122822 |
_version_ | 1784732461409763328 |
---|---|
author | Kouka, Mussab Koehler, Benjamin Buentzel, Jens Kaftan, Holger Boeger, Daniel Mueller, Andreas H. Wittig, Andrea Schultze-Mosgau, Stefan Ernst, Thomas Schlattmann, Peter Guntinas-Lichius, Orlando |
author_facet | Kouka, Mussab Koehler, Benjamin Buentzel, Jens Kaftan, Holger Boeger, Daniel Mueller, Andreas H. Wittig, Andrea Schultze-Mosgau, Stefan Ernst, Thomas Schlattmann, Peter Guntinas-Lichius, Orlando |
author_sort | Kouka, Mussab |
collection | PubMed |
description | SIMPLE SUMMARY: The prognostic role of intraparotid (PAR) and cervical lymph node (LN) metastasis on overall survival (OS) of primary parotid cancer is unclear. All 345 Thuringian patients with parotid cancer from 1996 to 2016 were included in a population-based study. OS was assessed in relation to the total number of removed PAR and cervical LN, number of positive intraparotid (PAR+), positive cervical LN, LN ratio, log odds of positive LN (LODDS), as well as including the PAR as LODDS-PAR. PAR was assessed in 42% of the patients (22% of these PAR+). T and N classification were not independent predictors of OS. When combining T with LODDS instead of N, higher T became a strong prognosticator, but not LODDS. When combining T classification with LODDS-PAR, both higher T classification and the classification with LODDS-PAR became independent predictors of worse OS. LODDS-PAR seems to be an optimal prognosticator for OS in primary parotid cancer. ABSTRACT: This population-based study investigated the prognostic role of intraparotid (PAR) and cervical lymph node (LN) metastasis on overall survival (OS) of primary parotid cancer. All 345 patients (median age: 66 years; 43% female, 49% N+, 31% stage IV) of the Thuringian cancer registries with parotid cancer from 1996 to 2016 were included. OS was assessed in relation to the total number of removed PAR and cervical LN, number of positive intraparotid (PAR+), positive cervical LN, LN ratio, log odds of positive LN (LODDS), as well as including the PAR as LODDS-PAR. PAR was assessed in 42% of the patients (22% of these PAR+). T and N classification were not independent predictors of OS. When combining T with LODDS instead of N, higher T (T3/T4) became a prognosticator (hazard ratio (HR) = 2.588; CI = 1.329–5.040; p = 0.005) but not LODDS (p > 0.05). When combining T classification with LODDS-PAR, both higher T classification (HR = 2.256; CI = 1.288–3.950; p = 0.004) and the alternative classification with LODDS-PAR (≥median −1.11; HR 2.078; CI = 1.155–3.739; p = 0.015) became independent predictors of worse OS. LODDS-PAR was the only independent prognosticator out of the LN assessment for primary parotid cancer. |
format | Online Article Text |
id | pubmed-9220808 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92208082022-06-24 Role of Intraparotid and Neck Lymph Node Metastasis in Primary Parotid Cancer Surgery: A Population-Based Analysis Kouka, Mussab Koehler, Benjamin Buentzel, Jens Kaftan, Holger Boeger, Daniel Mueller, Andreas H. Wittig, Andrea Schultze-Mosgau, Stefan Ernst, Thomas Schlattmann, Peter Guntinas-Lichius, Orlando Cancers (Basel) Article SIMPLE SUMMARY: The prognostic role of intraparotid (PAR) and cervical lymph node (LN) metastasis on overall survival (OS) of primary parotid cancer is unclear. All 345 Thuringian patients with parotid cancer from 1996 to 2016 were included in a population-based study. OS was assessed in relation to the total number of removed PAR and cervical LN, number of positive intraparotid (PAR+), positive cervical LN, LN ratio, log odds of positive LN (LODDS), as well as including the PAR as LODDS-PAR. PAR was assessed in 42% of the patients (22% of these PAR+). T and N classification were not independent predictors of OS. When combining T with LODDS instead of N, higher T became a strong prognosticator, but not LODDS. When combining T classification with LODDS-PAR, both higher T classification and the classification with LODDS-PAR became independent predictors of worse OS. LODDS-PAR seems to be an optimal prognosticator for OS in primary parotid cancer. ABSTRACT: This population-based study investigated the prognostic role of intraparotid (PAR) and cervical lymph node (LN) metastasis on overall survival (OS) of primary parotid cancer. All 345 patients (median age: 66 years; 43% female, 49% N+, 31% stage IV) of the Thuringian cancer registries with parotid cancer from 1996 to 2016 were included. OS was assessed in relation to the total number of removed PAR and cervical LN, number of positive intraparotid (PAR+), positive cervical LN, LN ratio, log odds of positive LN (LODDS), as well as including the PAR as LODDS-PAR. PAR was assessed in 42% of the patients (22% of these PAR+). T and N classification were not independent predictors of OS. When combining T with LODDS instead of N, higher T (T3/T4) became a prognosticator (hazard ratio (HR) = 2.588; CI = 1.329–5.040; p = 0.005) but not LODDS (p > 0.05). When combining T classification with LODDS-PAR, both higher T classification (HR = 2.256; CI = 1.288–3.950; p = 0.004) and the alternative classification with LODDS-PAR (≥median −1.11; HR 2.078; CI = 1.155–3.739; p = 0.015) became independent predictors of worse OS. LODDS-PAR was the only independent prognosticator out of the LN assessment for primary parotid cancer. MDPI 2022-06-07 /pmc/articles/PMC9220808/ /pubmed/35740490 http://dx.doi.org/10.3390/cancers14122822 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kouka, Mussab Koehler, Benjamin Buentzel, Jens Kaftan, Holger Boeger, Daniel Mueller, Andreas H. Wittig, Andrea Schultze-Mosgau, Stefan Ernst, Thomas Schlattmann, Peter Guntinas-Lichius, Orlando Role of Intraparotid and Neck Lymph Node Metastasis in Primary Parotid Cancer Surgery: A Population-Based Analysis |
title | Role of Intraparotid and Neck Lymph Node Metastasis in Primary Parotid Cancer Surgery: A Population-Based Analysis |
title_full | Role of Intraparotid and Neck Lymph Node Metastasis in Primary Parotid Cancer Surgery: A Population-Based Analysis |
title_fullStr | Role of Intraparotid and Neck Lymph Node Metastasis in Primary Parotid Cancer Surgery: A Population-Based Analysis |
title_full_unstemmed | Role of Intraparotid and Neck Lymph Node Metastasis in Primary Parotid Cancer Surgery: A Population-Based Analysis |
title_short | Role of Intraparotid and Neck Lymph Node Metastasis in Primary Parotid Cancer Surgery: A Population-Based Analysis |
title_sort | role of intraparotid and neck lymph node metastasis in primary parotid cancer surgery: a population-based analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220808/ https://www.ncbi.nlm.nih.gov/pubmed/35740490 http://dx.doi.org/10.3390/cancers14122822 |
work_keys_str_mv | AT koukamussab roleofintraparotidandnecklymphnodemetastasisinprimaryparotidcancersurgeryapopulationbasedanalysis AT koehlerbenjamin roleofintraparotidandnecklymphnodemetastasisinprimaryparotidcancersurgeryapopulationbasedanalysis AT buentzeljens roleofintraparotidandnecklymphnodemetastasisinprimaryparotidcancersurgeryapopulationbasedanalysis AT kaftanholger roleofintraparotidandnecklymphnodemetastasisinprimaryparotidcancersurgeryapopulationbasedanalysis AT boegerdaniel roleofintraparotidandnecklymphnodemetastasisinprimaryparotidcancersurgeryapopulationbasedanalysis AT muellerandreash roleofintraparotidandnecklymphnodemetastasisinprimaryparotidcancersurgeryapopulationbasedanalysis AT wittigandrea roleofintraparotidandnecklymphnodemetastasisinprimaryparotidcancersurgeryapopulationbasedanalysis AT schultzemosgaustefan roleofintraparotidandnecklymphnodemetastasisinprimaryparotidcancersurgeryapopulationbasedanalysis AT ernstthomas roleofintraparotidandnecklymphnodemetastasisinprimaryparotidcancersurgeryapopulationbasedanalysis AT schlattmannpeter roleofintraparotidandnecklymphnodemetastasisinprimaryparotidcancersurgeryapopulationbasedanalysis AT guntinaslichiusorlando roleofintraparotidandnecklymphnodemetastasisinprimaryparotidcancersurgeryapopulationbasedanalysis |